Suppr超能文献

使用中截流膜和高通量膜进行血液透析患者的外周血淋巴细胞亚群:THE SHE 延续性研究

Peripheral Blood Lymphocyte Subgroups in Patients Undergoing Hemodialysis with Medium Cutoff Membranes and High-Flux Membranes: THE SHE Continuation Study.

作者信息

Hasbal Nuri Baris, Sevinc Mustafa, Yilmaz Vuslat, Yilmaz Abdullah, Yuceer Korkmaz Hande, Basturk Taner, Ahbap Elbis, Sakaci Tamer, Lindholm Bengt, Unsal Abdulkadir

机构信息

Division of Nephrology, Department of Internal Medicine, Koc University School of Medicine, Istanbul, Turkey.

Department of Nephrology, Manchester University NHS Trust, Manchester Royal Infirmary Hospital, Manchester, UK.

出版信息

Blood Purif. 2024;53(11-12):937-946. doi: 10.1159/000541200. Epub 2024 Aug 30.

Abstract

INTRODUCTION

Chronic kidney disease (CKD) poses a significant global health burden, with increasing prevalence and high morbidity and mortality rates, particularly in end-stage kidney disease (ESKD). While traditional risk factors contribute, the exact mechanisms remain elusive, with inflammation playing a pivotal role. Medium cutoff (MCO) membranes offer promise in improving dialysis outcomes by efficiently clearing uremic toxins without substantial albumin loss. We aimed to elucidate the impact of MCO and high-flux (HF) membranes on peripheral blood lymphocyte subpopulations in hemodialysis patients.

METHODS

Twenty-four ESKD patients underwent 36 sessions each with MCO and HF membranes. Immunophenotyping by flow cytometry was performed to analyze lymphocyte subsets.

RESULTS

NK cell percentages significantly increased with MCO, returning to baseline with HF. Th1 cells decreased post-HF, while Th2 and Tfh cells increased with MCO and persisted. Treg cells remained stable with MCO but decreased with HF.

CONCLUSION

MCO dialysis induced an anti-inflammatory shift, evidenced by increased Th2 and Tfh cells and stable Treg cells. NK cells also responded favorably to MCO. These findings underscore MCO membranes' potential to modulate immune responses and improve patient outcomes in ESKD.

摘要

引言

慢性肾脏病(CKD)给全球健康带来了重大负担,其患病率不断上升,发病率和死亡率居高不下,尤其是在终末期肾病(ESKD)患者中。虽然传统风险因素起了一定作用,但其确切机制仍不清楚,炎症在其中起着关键作用。中截流(MCO)膜有望通过有效清除尿毒症毒素而不导致大量白蛋白流失来改善透析效果。我们旨在阐明MCO膜和高通量(HF)膜对血液透析患者外周血淋巴细胞亚群的影响。

方法

24例ESKD患者分别使用MCO膜和HF膜进行了36次透析治疗。通过流式细胞术进行免疫表型分析以分析淋巴细胞亚群。

结果

使用MCO膜时NK细胞百分比显著增加,使用HF膜时恢复至基线水平。HF透析后Th1细胞减少,而Th2和滤泡辅助性T(Tfh)细胞在使用MCO膜时增加并持续存在。使用MCO膜时调节性T(Treg)细胞保持稳定,但使用HF膜时减少。

结论

MCO透析诱导了抗炎转变,表现为Th2和Tfh细胞增加以及Treg细胞稳定。NK细胞对MCO膜也有良好反应。这些发现强调了MCO膜在调节免疫反应和改善ESKD患者预后方面的潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验